leisure time -WSS

leisure time

author：fashion 2025-09-02 17:36:03 - browse：46

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Pharmacists can make shortage drugs, but at what cost?

WSS

Crowdfunding for medical bills sidesteps core problem, author says

Eli Lilly expects to double planned employment in Boston center

Novel spinal cord stimulator treats paralysis without surgery

Class action alleges UnitedHealth concealed DOJ probe

STAT Summit: GSK CEO on pharma giant's new direction

AltruBio raises $225 million to develop ulcerative colitis drug

knowledge

leisure time

explore

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

FDA warns J&J's Abiomed: We will regulate your software

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT Readout Newsletter: Today's biggest biotech updates

How to save PrEP access — and even expand it

Brain MRIs reveal impact of 'toxic stress' on Black children

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Chemotherapy before breast cancer surgery might fuel metastasis

Hepatitis C has a cure — but many Americans still lack access to it

Warren pushes Witty on UnitedHealth's control over physicians

entertainment

Can gargling with Listerine treat gonorrhea of the mouth?

Deliver public health messages at the right time

NIH confirmation hearing shows politicization of research

How climate

Impact of Dobbs ruling felt at reproductive medicine meeting

Class action alleges UnitedHealth concealed DOJ probe

entertainment

explore

focus

knowledge